Morgan Stanley
KMTS

Morgan Stanley’s Kestra Medical Technologies KMTS Stock Holding History

Morgan Stanley’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.9M Buy
145,561
+60,109
+70% +$1.42M ﹤0.01% 4493
2025
Q4 		$2.27M Buy
85,452
+41,587
+95% +$1.07M ﹤0.01% 4723
2025
Q3 		$1.04M Buy
43,865
+2,223
+5% +$39.8K ﹤0.01% 5154
2025
Q2 		$690K Buy
41,642
+36,854
+770% +$805K ﹤0.01% 5298
2025
Q1 		$119K Buy
+4,788
New +$110K ﹤0.01% 5935

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley's KMTS Position: Q1 2026 in Review

Morgan Stanley increased its Kestra Medical Technologies (KMTS) stake by 70% in Q1 2026, buying an estimated $1.42M and bringing the position to 145,561 shares worth $2.9M. The position accounts for ﹤0.01% of the portfolio, ranked #4493.

Morgan Stanley first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Morgan Stanley held 145,561 shares of Kestra Medical Technologies worth $2.9M as of Q1 2026.
  • Morgan Stanley bought 60,109 Kestra Medical Technologies shares in Q1 2026, an estimated $1.42M.
  • Kestra Medical Technologies made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4493 holding.
  • Morgan Stanley first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.